Effect of exenatide on cortisol secretion
Phase of Trial: Phase IV
Latest Information Update: 09 May 2018
At a glance
- Drugs Exenatide (Primary)
- Indications Metabolic disorders; Obesity; Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Therapeutic Use
- 02 May 2018 Status changed from recruiting to completed.
- 06 Sep 2017 Status changed from not yet recruiting to recruiting.
- 22 Jun 2017 New trial record